The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue
2011 · British Journal of Cancer · 92 citations
https://doi.org/10.1038/sj.bjc.6606055
A
A O’Grady
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
1.0K
Citations
20
h-index
26
i10-index
A O’Grady is an academic researcher from Tallaght University Hospital. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research & Nonmelanoma Skin Cancer Studies. The author has an h-index of 20, co-authored 47 publications.
Papers by this author
worksDifferential expression of matrix metalloproteinase (MMP)‐2, MMP‐9 and tissue inhibitor of metalloproteinase (TIMP)‐1 and TIMP‐2 in non‐melanoma skin cancer: implications for tumour progression
2007 · Histopathology · 87 citations
https://doi.org/10.1111/j.1365-2559.2007.02885.x
HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods
2011 · Journal of Clinical Pathology · 77 citations
https://doi.org/10.1136/jcp.2011.089847
The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study
2011 · British Journal of Cancer · 71 citations
https://doi.org/10.1038/bjc.2011.408
A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib
2014 · Breast Cancer Research and Treatment · 49 citations
https://doi.org/10.1007/s10549-014-3239-5
SECURE Study: Early Findings Suggest MGUS Diagnosis Does Not Increase Psychological Distress
2025 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(25)03810-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat